India, June 19 -- Aurobindo Pharma has received approval from the US Federal Trade Commission (FTC) for its proposed acquisition of Lannett Company LLC through its wholly owned subsidiary, Aurobindo Pharma USA Inc.
The company had announced in July 2025 that Aurobindo Pharma USA entered into a definitive agreement with LANNETT SELLER HOLDCO, INC. to acquire 100% membership interest in Lannett Company LLC.
With the regulatory clearance now in place, Aurobindo Pharma expects to complete the transaction before the end of the current month. The company stated that it will continue to update stock exchanges regarding any further developments related to the acquisition.
Published by HT Digital Content Services with permission from Dion Global ...